Page last updated: 2024-10-24

chloroquine and Diabetes Insipidus

chloroquine has been researched along with Diabetes Insipidus in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Diabetes Insipidus: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winslow, J1

Other Studies

1 other study available for chloroquine and Diabetes Insipidus

ArticleYear
[Diabetes insipidus in patients with sarcoidosis].
    Ugeskrift for laeger, 1971, Mar-19, Volume: 133, Issue:11

    Topics: Adolescent; Chloroquine; Chlorpropamide; Diabetes Insipidus; Female; Humans; Prednisone; Sarcoidosis

1971